SEC Form 4 · accession 0001013606-16-000263
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M. Jennings
Officer — VP-Human Resources
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | A | 7,535 | $0.00 | A | 51,238 | D | |
| Common StockF2 | Jun 1, 2016 | S | 957 | $12.55 | D | 50,281 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on June 1, 2015. 33% percent of the shares subject to this award vested upon one year of service.
- F2Shares sold on June 1, 2016 to satisfy statutory minimum tax withholding obligations related to Restricted Stock Unit shares vested on May 28, 2016.
Remarks
The reporting person's beginning share balance includes a number of shares issued under the company's Employee Stock Purchase Plan not previously reported to the Securities and Exchange Commission as the number of share was deemed immaterial by the company.